Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Ann Oncol. 2014 Sep:25 Suppl 3:iii57-69. doi: 10.1093/annonc/mdu180. Epub 2014 Jul 25.

Authors

P Fenaux¹, D Haase², G F Sanz³, V Santini⁴, C Buske⁵; ESMO Guidelines Working Group

Collaborators

Affiliations

¹ Service d'Hématologie Clinique, Groupe Francophone des Myélodysplasies (GFM), Hôpital St Louis (Assistance Publique, Hôpitaux de Paris) and Paris 7 University, Paris, France.
² Clinics of Hematology and Medical Oncology, University Medicine, Goettingen, Germany.
³ Department of Haematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
⁴ Functional Unit of Haematology, AOU Careggi, University of Florence, Firenze, Italy.
⁵ Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, University Hospital, Ulm, Germany.

PMID: 25185242
DOI: 10.1093/annonc/mdu180

No abstract available

Publication types

Practice Guideline

MeSH terms

Combined Modality Therapy
Follow-Up Studies
Health Planning Guidelines*
Humans
Myelodysplastic Syndromes / diagnosis*
Myelodysplastic Syndromes / therapy*
Neoplasm Staging
Prognosis
Societies, Medical / standards*